Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Prostate cancer
Closed
Phase 3
This trial is for men with prostate cancer that has spread and is getting worse despite having hormone therapy or having their testicles removed. This is called metastatic castration resistant prostate cancer.
The trial is comparing the combination of pembrolizumab and olaparib with:
abiraterone and prednisolone or
enzalutamide on its own
Recruitment start: 24 September 2019
Recruitment end: 9 June 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Johann de Bono
Merck Sharp & Dohme Ltd
Last reviewed: 21 Jun 2021
CRUK internal database number: 17104
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
